Aeon Global Health Quick Ratio (ADAT) starting from the third quarter 2019 to third quarter 2016, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Aeon Global Health Corp.  (ADAT)

Aeon Global Health's Quick Ratio

ADAT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Aeon Global Health's Cash & cash equivalent grew by 45.87 % in the Q3 2019 sequentially, while Current Liabilities decreased, this led to improvement in Aeon Global Health's Quick Ratio to 0.07, Quick Ratio remained below Aeon Global Health Corp. average.

Within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than Aeon Global Health in third quarter 2019. While Quick Ratio total ranking in the third quarter 2019 has deteriorated compared to the prior quarter from to 4485.

Explain Quick Ratio?
How much Cash & cash equivalents ADAT´s has?
What are ADAT´s Current Liabilities?




ADAT Quick Ratio (Mar 31 2019)
Q3
(Dec 31 2017)
Q2
(Sep 30 2017)
Q1
(Jun 30 2017)
Q4
(Dec 31 2016)
Q2
Y / Y Current Liabilities Change -13.13 % -48.66 % -24.22 % -13.97 % 191.1 %
Y / Y Cash & cash equivalent Change 9.28 % -50.49 % -52.21 % -56.92 % -86.97 %
Quick Ratio MRQ 0.07 0.04 0.08 0.14 0.05
ADAT's Total Ranking # 4485 # # # #
Seq. Current Liabilities Change -6.66 % -5.32 % 1.7 % -3.36 % -44.83 %
Seq. Cash & cash equivalent Change 45.87 % -51.33 % -40.94 % 160.6 % -33.91 %



Quick Ratio third quarter 2019 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 22
Healthcare Sector # 881
Overall Market # 4485


Quick Ratio Statistics
High Average Low
1.19 0.23 0.04
(Dec 31 2013)   (Dec 31 2017)




Financial Statements
Aeon Global Health's Current Liabilities $ 8 Millions Visit ADAT's Balance sheet
Aeon Global Health's Cash & cash equivalent $ 1 Millions Visit ADAT's Balance sheet
Source of ADAT's Sales Visit ADAT's Sales by Geography


Cumulative Aeon Global Health's Quick Ratio

ADAT's Quick Ratio for the trailling 12 Months

ADAT Quick Ratio

(Mar 31 2019)
12 Months
(Dec 31 2017)
12 Months
(Sep 30 2017)
12 Months
(Jun 30 2017)
12 Months
(Dec 31 2016)
12 Months
Y / Y Current Liabilities TTM Growth -28.37 % -15.22 % 72.29 % 246.05 % 1423.32 %
Y / Y Cash & cash equivalent TTM Growth -49.19 % -68.07 % -60.71 % -39.24 % 53.49 %
Quick Ratio TTM 0.09 0.08 0.07 0.09 0.12
Total Ranking TTM # 5295 # # # #
Seq. Current Liabilities TTM Growth -3.39 % -18.52 % -6.19 % -3 % 14.34 %
Seq. Cash & cash equivalent TTM Growth 1.57 % -11.47 % -20.16 % -29.22 % -36.17 %


On the trailing twelve months basis ADAT Cash & cash equivalent improved by 9.28 % in Q3 2019 year on year, while Current Liabilities decreased to $8 millions, this led to increase in in Aeon Global Health's Quick Ratio to 0.09, Quick Ratio remained below ADAT average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 23 other companies have achieved higher Quick Ratio than Aeon Global Health. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2017 from to 5295.

Explain Quick Ratio?
How much Cash & cash equivalents ADAT´s has?
What are ADAT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 24
Healthcare Sector # 925
Within the Market # 5295


trailing twelve months Quick Ratio Statistics
High Average Low
0.21 0.11 0.07
(Sep 30 2016)   (Sep 30 2017)




Companies with similar Quick Ratio in the quarter ending Mar 31 2019, within Laboratory Analytical Instruments Industry Quick RatioMar 31 2019 MRQ Cash & cash equivalentMar 31 2019 MRQ Current Liabilities
Aeon Global Health Corp.  0.07 $ 0.521  Millions$ 7.781  Millions
Pressure Biosciences Inc   0.03 $ 0.270  Millions$ 9.190  Millions

Date modified: 2026-09-08T15:22:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.